Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG
View ORCID ProfileVeronica P. Costantini, View ORCID ProfileKenny Nguyen, View ORCID ProfileZoe Lyski, Shannon Novosad, Ana C. Bardossy, View ORCID ProfileAmanda K. Lyons, Paige Gable, View ORCID ProfilePreeta K. Kutty, View ORCID ProfileJoseph D. Lutgring, View ORCID ProfileAmanda Brunton, View ORCID ProfileNatalie Thornburg, View ORCID ProfileAllison C. Brown, L. Clifford McDonald, View ORCID ProfileWilliam Messer, View ORCID ProfileJan Vinjé
doi: https://doi.org/10.1101/2021.09.03.21263078
Veronica P. Costantini
1Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
Kenny Nguyen
2Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37830
Zoe Lyski
3Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA
Shannon Novosad
4Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
Ana C. Bardossy
4Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
Amanda K. Lyons
4Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
Paige Gable
4Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
Preeta K. Kutty
4Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
Joseph D. Lutgring
4Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
Amanda Brunton
3Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA
Natalie Thornburg
1Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
Allison C. Brown
4Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
L. Clifford McDonald
4Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
William Messer
3Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA
5School of Public Health, Oregon Health & Science University, Portland, OR 97239, USA
6Department of Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, OR 97239, USA
Jan Vinjé
1Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
Posted September 07, 2021.
Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG
Veronica P. Costantini, Kenny Nguyen, Zoe Lyski, Shannon Novosad, Ana C. Bardossy, Amanda K. Lyons, Paige Gable, Preeta K. Kutty, Joseph D. Lutgring, Amanda Brunton, Natalie Thornburg, Allison C. Brown, L. Clifford McDonald, William Messer, Jan Vinjé
medRxiv 2021.09.03.21263078; doi: https://doi.org/10.1101/2021.09.03.21263078
Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG
Veronica P. Costantini, Kenny Nguyen, Zoe Lyski, Shannon Novosad, Ana C. Bardossy, Amanda K. Lyons, Paige Gable, Preeta K. Kutty, Joseph D. Lutgring, Amanda Brunton, Natalie Thornburg, Allison C. Brown, L. Clifford McDonald, William Messer, Jan Vinjé
medRxiv 2021.09.03.21263078; doi: https://doi.org/10.1101/2021.09.03.21263078
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2661)
- Dermatology (224)
- Emergency Medicine (402)
- Epidemiology (12264)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2670)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (441)
- Neurology (3912)
- Nursing (210)
- Nutrition (582)
- Oncology (2048)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (455)
- Public and Global Health (6551)
- Radiology and Imaging (1410)
- Respiratory Medicine (872)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)